ctrl K

Watchlist Price Alert

ARS Pharmaceuticals Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

13.46

-0.03 (-0.22%)

At close: May 09, 2025, 3:59 PM

13.33

-1.00%

After-hours: May 09, 2025, 07:27 PM EDT

ARS Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024
Product Revenue	7.25M
Product Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Selling, General, and Administrative Revenue	35.5M	19.28M	8.94M	7.95M	6.81M	14.98M	13.3M	12.18M	10.73M	2.93M	2.46M	2.34M	7.39M	6.7M	6.48M	6.37M	3.99M	1.07M	566K	263K
Selling, General, and Administrative Revenue Growth	+84.13%	+115.57%	+12.55%	+16.70%	-54.53%	+12.56%	+9.23%	+13.49%	+266.81%	+19.04%	+5.09%	-68.36%	+10.31%	+3.47%	+1.74%	+59.63%	+272.01%	+89.40%	+115.21%	n/a
Research and Development Revenue	3.03M	4.42M	6.9M	5.23M	3.4M	3M	7.31M	6.55M	4.71M	3.89M	4.35M	5.42M	15.68M	15.44M	17.54M	12.05M	8.65M	4.99M	4.28M	6.27M
Research and Development Revenue Growth	-31.56%	-35.86%	+31.75%	+53.76%	+13.39%	-58.92%	+11.54%	+39.11%	+20.99%	-10.51%	-19.79%	-65.42%	+1.59%	-11.99%	+45.54%	+39.37%	+73.38%	+16.68%	-31.85%	n/a